MedPath

Study of skin and biopsy features in children with Langerhans cell histiocytosis

Not yet recruiting
Conditions
Other disorders of the skin and subcutaneous tissue,
Registration Number
CTRI/2021/12/039007
Lead Sponsor
ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Brief Summary

Langerhanscell histiocytosis is a clonal proliferative disorder of histiocytes characterizedby accumulation of CD1a + Langerhans cells in various organs. There is a scarcity of information regardingvarious cutaneous and histological presentations of this disease. Some studieshave indicated a prognostic role of few cutaneous and histological findings of Langerhanscell histiocytosis. Thus, this study will aim to describe the clinical andhistological findings of this condition and their correlation with frequencyand severity of systemic involvement.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Children with clinical and histological diagnosis of Langerhans cell histiocytosis.

Exclusion Criteria
  • Children with a doubtful diagnosis of Langerhans cell histiocytosis 2.
  • Parents not willing to participate in this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Description of clinical and histological features in children with Langerhans cell histiocytosisBaseline
Secondary Outcome Measures
NameTimeMethod
Correlation of these clinical and histological features with frequency and severity of systemic involvement in children with Langerhans cell histiocytosisBaseline

Trial Locations

Locations (1)

All India Institute of Medical Science

🇮🇳

Delhi, DELHI, India

All India Institute of Medical Science
🇮🇳Delhi, DELHI, India
Dr Avik Mondal
Principal investigator
7908072776
avik.mondal11@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.